跳至主要内容
临床试验/CTRI/2019/09/021451
CTRI/2019/09/021451进行中(未招募)未知

A Prospective, Multicentric, Non- Interventional Real-World, Data Collection Registry to Evaluate the Effectiveness, Safety and Durability of SUPERA Stent for the Treatment of De Novo or Restenotic Superficial Femoral Artery or Complex Femoropopliteal Artery Lesions in Indian patients

Dr Rajiv Parakh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients of either sex aged >=18 years.
  • 2. Patients willing to sign the informed consent form (ICF) to share the data.
  • 3. Patients with de novo or restenotic lesions in the superficial femoral artery or femoropopliteal segment treated successfully ( <30% diameter stenosis with no procedural complications) with SUPERA stent.

排除标准

  • 1. Patients unwilling to sign the ICF.
  • 2. Patients with age <18 years or >90 years.
  • 3. Patients with other comorbidities that may limit life expectancy to less than one year.

研究者

发起方
Dr Rajiv Parakh

相似试验